These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

440 related items for PubMed ID: 18932207

  • 21. [Physiological approach to peripheral neuropathy. Conventional nerve conduction studies and magnetic motor root stimulation].
    Ugawa Y.
    Rinsho Shinkeigaku; 2004 Nov; 44(11):986-90. PubMed ID: 15651350
    [Abstract] [Full Text] [Related]

  • 22. The value of sensory electrophysiology in chronic inflammatory demyelinating polyneuropathy.
    Rajabally YA, Narasimhan M.
    Clin Neurophysiol; 2007 Sep; 118(9):1999-2004. PubMed ID: 17644033
    [Abstract] [Full Text] [Related]

  • 23. Threshold electrotonus in chronic inflammatory demyelinating polyneuropathy: correlation with clinical profiles.
    Sung JY, Kuwabara S, Kaji R, Ogawara K, Mori M, Kanai K, Nodera H, Hattori T, Bostock H.
    Muscle Nerve; 2004 Jan; 29(1):28-37. PubMed ID: 14694495
    [Abstract] [Full Text] [Related]

  • 24. Multifocal sensory demyelinating neuropathy: Report of a case.
    Oh SJ.
    Muscle Nerve; 2017 Oct; 56(4):825-828. PubMed ID: 28000233
    [Abstract] [Full Text] [Related]

  • 25. Different neurological and physiological profiles in POEMS syndrome and chronic inflammatory demyelinating polyneuropathy.
    Nasu S, Misawa S, Sekiguchi Y, Shibuya K, Kanai K, Fujimaki Y, Ohmori S, Mitsuma S, Koga S, Kuwabara S.
    J Neurol Neurosurg Psychiatry; 2012 May; 83(5):476-9. PubMed ID: 22338030
    [Abstract] [Full Text] [Related]

  • 26. A distinct subgroup of chronic inflammatory demyelinating polyneuropathy with CNS demyelination and a favorable response to immunotherapy.
    Pineda AA, Ogata K, Osoegawa M, Murai H, Shigeto H, Yoshiura T, Tobimatsu S, Kira J.
    J Neurol Sci; 2007 Apr 15; 255(1-2):1-6. PubMed ID: 17306302
    [Abstract] [Full Text] [Related]

  • 27. Length-dependent weakness and electrophysiological signs of secondary axonal loss in chronic inflammatory demyelinating polyradiculoneuropathy.
    Harbo T, Andersen H, Jakobsen J.
    Muscle Nerve; 2008 Aug 15; 38(2):1036-45. PubMed ID: 18642356
    [Abstract] [Full Text] [Related]

  • 28. Triple-stimulation technique improves the diagnosis of chronic inflammatory demyelinating polyradiculoneuropathy.
    Attarian S, Franques J, Elisabeth J, Trébuchon A, Duclos Y, Wybrecht D, Verschueren A, Salort-Campana E, Pouget J.
    Muscle Nerve; 2015 Apr 15; 51(4):541-8. PubMed ID: 25571892
    [Abstract] [Full Text] [Related]

  • 29. Criteria for demyelination based on the maximum slowing due to axonal degeneration, determined after warming in water at 37 degrees C: diagnostic yield in chronic inflammatory demyelinating polyneuropathy.
    Van Asseldonk JT, Van den Berg LH, Kalmijn S, Wokke JH, Franssen H.
    Brain; 2005 Apr 15; 128(Pt 4):880-91. PubMed ID: 15689367
    [Abstract] [Full Text] [Related]

  • 30. Sensory pathophysiology in chronic acquired demyelinating neuropathy.
    Krarup C, Trojaborg W.
    Brain; 1996 Feb 15; 119 ( Pt 1)():257-70. PubMed ID: 8624687
    [Abstract] [Full Text] [Related]

  • 31. Somatosensory evoked potentials (SSEPs); sensory nerve conduction velocity (SNCV) and motor nerve conduction velocity (MNCV) in chronic renal failure.
    Makkar RK, Kochar DK.
    Electromyogr Clin Neurophysiol; 1994 Feb 15; 34(5):295-300. PubMed ID: 7956880
    [Abstract] [Full Text] [Related]

  • 32. Research criteria for defining patients with CIDP.
    Sander HW, Latov N.
    Neurology; 2003 Apr 01; 60(8 Suppl 3):S8-15. PubMed ID: 12707417
    [Abstract] [Full Text] [Related]

  • 33. Child neurology: chronic inflammatory demyelinating polyradiculoneuropathy in children.
    Markowitz JA, Jeste SS, Kang PB.
    Neurology; 2008 Dec 02; 71(23):e74-8. PubMed ID: 19047554
    [Abstract] [Full Text] [Related]

  • 34. Distal acquired demyelinating symmetric polyneuropathy progressing to classic chronic inflammatory demyelinating polyneuropathy and response to fludarabine and cyclophosphamide.
    Leitch MM, Sherman WH, Brannagan TH.
    Muscle Nerve; 2013 Feb 02; 47(2):292-6. PubMed ID: 23168526
    [Abstract] [Full Text] [Related]

  • 35. Chronic Inflammatory Demyelinating Polyneuropathy.
    Kuwabara S, Misawa S.
    Adv Exp Med Biol; 2019 Feb 02; 1190():333-343. PubMed ID: 31760654
    [Abstract] [Full Text] [Related]

  • 36. Sensory CIDP presenting as cryptogenic sensory polyneuropathy.
    Chin RL, Latov N, Sander HW, Hays AP, Croul SE, Magda P, Brannagan TH.
    J Peripher Nerv Syst; 2004 Sep 02; 9(3):132-7. PubMed ID: 15363060
    [Abstract] [Full Text] [Related]

  • 37. A prospective evaluation of phrenic nerve conduction in multifocal motor neuropathy and chronic inflammatory demyelinating polyneuropathy.
    Macia F, Le Masson G, Rouanet-Larriviere M, Habonimana D, Ferrer X, Marthan R, Lagueny A.
    Muscle Nerve; 2003 Sep 02; 28(3):319-23. PubMed ID: 12929191
    [Abstract] [Full Text] [Related]

  • 38. Electrophysiological sensory demyelination in typical chronic inflammatory demyelinating polyneuropathy.
    Rajabally YA, Samarasekera S.
    Eur J Neurol; 2010 Jul 02; 17(7):939-44. PubMed ID: 20158514
    [Abstract] [Full Text] [Related]

  • 39. A Severe Form of M - protein Negative Distal Acquired Demyelinating Symmetric Neuropathy.
    Ong TL, Goh KJ, Shahrizaila N, Wong KT, Tan CY.
    Neurol India; 2019 Jul 02; 67(6):1532-1535. PubMed ID: 31857554
    [Abstract] [Full Text] [Related]

  • 40. A comparison of clinically atypical with typical chronic inflammatory demyelinating polyradiculoneuropathy.
    Misra UK, Kalita J, Yadav RK.
    Eur Neurol; 2007 Jul 02; 58(2):100-5. PubMed ID: 17565223
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 22.